UK markets open in 2 hours 52 minutes
NIKKEI 225
37,910.76 +282.28 (+0.75%) HANG SENG
17,616.34 +331.80 (+1.92%) CRUDE OIL
83.82 +0.25 (+0.30%) GOLD FUTURES
2,346.70 +4.20 (+0.18%) DOW
38,085.80 -375.12 (-0.98%) Bitcoin GBP
51,490.97 +84.71 (+0.16%)
Globus Medical, Inc. (GMED)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 6.82B |
| Enterprise value | 6.82B |
| Trailing P/E | 47.07 |
| Forward P/E | 18.76 |
| PEG ratio (5-yr expected) | 1.71 |
| Price/sales (ttm) | 3.68 |
| Price/book (mrq) | 1.71 |
| Enterprise value/revenue | 4.35 |
| Enterprise value/EBITDA | 19.68 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.10 |
| 52-week change 3 | -13.36% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 62.88 |
| 52-week low 3 | 43.39 |
| 50-day moving average 3 | 53.04 |
| 200-day moving average 3 | 52.53 |
Share statistics
| Avg vol (3-month) 3 | 1.04M |
| Avg vol (10-day) 3 | 913.39k |
| Shares outstanding 5 | 112.94M |
| Implied shares outstanding 6 | 138.25M |
| Float 8 | 111.92M |
| % held by insiders 1 | 0.79% |
| % held by institutions 1 | 97.32% |
| Shares short (15 Apr 2024) 4 | 7.51M |
| Short ratio (15 Apr 2024) 4 | 7.36 |
| Short % of float (15 Apr 2024) 4 | 6.70% |
| Short % of shares outstanding (15 Apr 2024) 4 | 5.55% |
| Shares short (prior month 15 Mar 2024) 4 | 5.86M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 7.83% |
| Operating margin (ttm) | 12.74% |
Management effectiveness
| Return on assets (ttm) | 4.77% |
| Return on equity (ttm) | 4.21% |
Income statement
| Revenue (ttm) | 1.57B |
| Revenue per share (ttm) | 13.87 |
| Quarterly revenue growth (yoy) | 124.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 418.24M |
| Net income avi to common (ttm) | 122.87M |
| Diluted EPS (ttm) | 1.05 |
| Quarterly earnings growth (yoy) | -70.00% |
Balance sheet
| Total cash (mrq) | 517.79M |
| Total cash per share (mrq) | 3.83 |
| Total debt (mrq) | 521.22M |
| Total debt/equity (mrq) | 13.04% |
| Current ratio (mrq) | 4.88 |
| Book value per share (mrq) | 29.32 |
Cash flow statement
| Operating cash flow (ttm) | 243.5M |
| Levered free cash flow (ttm) | -346.92M |
© 2024 Yahoo. All rights reserved.